VANGUARD GROUP INC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$3,608,098
-27.4%
2,283,606
-0.7%
0.00%
Q2 2023$4,969,542
+13.0%
2,300,714
+9.9%
0.00%
Q1 2023$4,397,940
+76.1%
2,094,257
+83.7%
0.00%
Q4 2022$2,496,876
-26.9%
1,140,126
+0.1%
0.00%
Q3 2022$3,418,000
+6.0%
1,139,5330.0%0.00%
Q2 2022$3,225,000
-47.1%
1,139,5330.0%0.00%
Q1 2022$6,097,000
-26.7%
1,139,533
+2.4%
0.00%
Q4 2021$8,315,000
+1.0%
1,113,191
+22.8%
0.00%
Q3 2021$8,234,000
+183.5%
906,741
+52.3%
0.00%
Q2 2021$2,904,000
+121.2%
595,202
+101.7%
0.00%
Q1 2021$1,313,000
+35.2%
295,105
+18.0%
0.00%
Q4 2020$971,000
+28.6%
250,147
+7.0%
0.00%
Q3 2020$755,000
-23.4%
233,850
+5.4%
0.00%
Q2 2020$985,000
+58.6%
221,9380.0%0.00%
Q1 2020$621,000
-10.0%
221,938
+34.0%
0.00%
Q4 2019$690,000
+18.4%
165,583
-0.5%
0.00%
Q3 2019$583,000166,4830.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 282,420$1,511,0002.38%
Tikvah Management LLC 1,350,833$7,227,0002.31%
Stonepine Capital Management, LLC 601,580$3,218,0001.34%
VR Adviser, LLC 1,398,889$7,484,0001.21%
TANG CAPITAL MANAGEMENT LLC 1,113,453$5,957,0001.19%
Deep Track Capital, LP 1,028,515$5,503,0000.35%
FEDERATED HERMES, INC. 5,222,250$27,939,0000.06%
Alyeska Investment Group, L.P. 760,798$4,070,0000.04%
Ikarian Capital, LLC 37,017$197,0000.03%
Baker Brothers Advisors 625,000$3,344,0000.02%
View complete list of ATYR PHARMA INC shareholders